Directorio de personas
Luis Brieva Ruiz

Luis Brieva Ruiz

Grado: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/E-8505-2019

Publicaciones

  • Lleixà C; Caballero-Ávila M; Pascual-Goñi E; Martín-Aguilar L; Vidal N; Tejada C; Valdés-Hevia E; Zárate E; Vesperinas A; Collet R; Franco-Leyva T; Martínez-Martínez L; Moga E; Cortés-Vicente E; Rojas-García R; Gómez-Anson B; Gil A; González-Mingot C; Brieva L; Martínez-Yélamos S; Querol L

    Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.

    Brain Communications 5 -. .

    [doi:10.1093/braincomms/fcad109]

  • Monreal, E; Fernandez-Velasco, JI; Garcia-Sanchez, MI; Sainz de la Maza S; Llufriu, S; Alvarez-Lafuente, R; Casanova, B; Comabella, M; Ramio-Torrenta, L; Martinez-Rodriguez, JE; Brieva, L; Saiz, A; Eichau, S; Cabrera-Maqueda, JM; Villarrubia, N; Espiño M; Perez-Miralles, F; Montalban, X; Tintore, M; Quiroga-Varela, A; Dominguez-Mozo, MI; Rodriguez-Jorge, F; Chico-Garcia, JL; Lourido, D; Alvarez-Cermeno, JC; Masjuan, J; Costa-Frossard, L; Villar, LM

    Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

    JAMA Neurology 80 397-403. .

    [doi:10.1001/jamaneurol.2023.0010]

  • de la Maza, SS; Gómez-Ballesteros, R; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervàs, M; Medrano, N; Maurino, J; Castillo-Triviño, T

    Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach

    Multiple Sclerosis Journal-Experimental Translational And Clinical 9 -. .

    [doi:10.1177/20552173231169475]

  • Río J.; Peña J.; Brieva L.; García-Domínguez J.M.; Rodríguez-Antigüedad A.; Oreja-Guevara C.; Costa-Frossard L.; Arroyo R.

    Monitoring response to disease-modifying treatment in multiple sclerosis

    Neurology Perspectives 3 -. .

    [doi:10.1016/j.neurop.2023.100119]

  • de la Maza, SS; Maurino, J; Castillo-Triviño, T; Borges, M; Torres, BS; Sotoca, J; Torres, AMA; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; Rodríguez-Regal, A; Navarro-Cantó, L; Agüera-Morales, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; Gómez-Ballesteros, R

    Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference And Adherence 17 1431-1439. .

    [doi:10.2147/PPA.S411069]

  • Saposnik, Gustavo; Andhavarapu, Sanketh; Sainz de la Maza S; Castillo-Trivino, Tamara; Borges, Monica; Baron, Beatriz Pardinas; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco, Maria R.; -Soto, Julio Dotor Garcia; del Campo-Amigo, Maria; Navarro-Canto, Laura; Agüera E; Garces, Moises; Carmona, Olga; Gabaldon -Torres, Laura; Forero, Lucia; Hervas, Mariona; Garcia-Arcelay, Elena; Terzaghi, Maria; Gomez-Ballesteros, Rocio; Maurino, Jorge

    Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.

    Multiple Sclerosis and Related Disorders 68 104138-104138. .

    [doi:10.1016/j.msard.2022.104138]

  • González-Mingot, C; Gil-Sánchez, A; Canudes-Solans, M; Peralta-Moncusi, S; Solana-Moga, MJ; Brieva-Ruiz, L

    Preventive treatment can reverse cognitive impairment in chronic migraine

    JOURNAL OF HEADACHE AND PAIN 23 -. .

    [doi:10.1186/s10194-022-01486-w]

  • Meca-Lallana, J E; Fernandez-Prada, M; Garcia Vazquez, E; Moreno Guillen, S; Otero Romero, S; Rus Hidalgo, M; Villar Guimerans, L M; Eichau Madueño S; Fernandez Fernandez, O; Izquierdo Ayuso, G; Álvarez Cermeño JC; Arnal Garcia, C; Arroyo Gonzalez, R; Brieva Ruiz, L; Calles Hernandez, C; Garcia Merino, A; Gonzalez Plata, M; Hernandez Perez, M A; Moral Torres, E; Olascoaga Urtaza, J; Oliva-Nacarino, P; Oreja-Guevara, C; Ortiz Castillo, R; Oterino, A; Prieto Gonzalez, J M; Ramio-Torrenta, L; Rodriguez-Antiguedad, A; Saiz, A; Tintore, M; Montalban Gairin, X

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

    Neurologia (barcelona, Spain) 37 615-630. .

    [doi:10.1016/j.nrleng.2019.11.001]

  • Solari, A; Montalban, X; Lechner-Scott, J; Piehl, F; Brochet, B; Langdon, D; Hupperts, R; Selmaj, K; Havrdova, EK; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B

    Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS

    MULTIPLE SCLEROSIS JOURNAL 28 203-204. .

  • Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.

    Gadolinium-enhanced brain lesions in multiple sclerosis relapse

    NEUROLOGIA 37 557-563. .

    [doi:10.1016/j.nrl.2021.10.005]

  • Castillo-Trivino, Tamara; Gomez-Ballesteros, Rocio; Borges, Monica; Martin-Martinez, Jesus; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco-Quilez, Maria R.; Garcia-Soto, Julio Dotor; del Campo-Amigo, Maria; Navarro-Canto, Laura; Aguera, Eduardo; Garces-Redondo, Moises; Carmona, Olga; Gabaldon-Torres, Laura; Forero, Lucia; Hervas, Mariona; Mauriño J; Sainz de la Maza S

    Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.

    Multiple Sclerosis and Related Disorders 64 103969-103969. .

    [doi:10.1016/j.msard.2022.103969]

  • Gonzalez-Mingot, C; Lopez-Ortega, R; Brieva-Ruiz, L

    The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2

    NEUROLOGICAL SCIENCES 43 5099-5101. .

    [doi:10.1007/s10072-022-06144-2]

Proyectos

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO